Quanta™ Dialysis System

Advancing Kidney Care Across the Patient Care Continuum

Quanta’s award-winning, innovative hemodialysis technology is expanding access to quality kidney care for patients in every care setting, from the hospital to the home.

Clinically Flexible

– Wide Qd range from 50-500 mL/min.
– FDA-cleared for HHD, IHD, SLED, and CRRT^1,3

Easy to Train

– Simple, intuitive , easy-to-operate system
– Train in as little as 4.5-6 hours²

Easy to Maintain

– NO daily rinses⁴
– NO harsh chemical disinfections⁴
– Batchless and bagless convenience

One platform. All hemodialysis modalities. Any care setting.

Quanta takes the complexity out of kidney replacement therapy while providing patients greater access to quality kidney care whenever, wherever it’s needed. Quanta’s flexible, intuitive, and easy-to-maintain platform is redefining how kidney care is delivered, from treating patients in the ICU to self-care patients in the home.

The Quanta Dialysis System is the first and only FDA-cleared device that offers every hemodialysis modality in one convenient platform, without any need for bags.

Award-Winning Technology

Quanta’s on-demand dialysate technology was awarded the prestigious Royal Academy of Engineering MacRobert Award in 2022.

2022:

Quanta received FDA-clearance to provide IHD, SLED, and bagless CRRT¹ all from a single platform.

2024:

Quanta received FDA clearance for home hemodialysis with a trained care partner following its successful HOME RUN clinical trial.^3,6

Acute Care Dialysis

Triple the Functionality, Triple the Benefits to Patient Care

The Quanta Dialysis System empowers ICU & dialysis teams to deliver dialysis care excellence by providing IHD, SLED, and CRRT¹ modalities on a single platform.

Standardized care: minimizes care delays and patient transfers
Precision dialysis: adjust prescriptions on-the-fly based on patient’s clinical needs (Qd from 50 to 500 mL/min, high-resolution control of Na+ and K+)
Cross-trained staff: Intuitive design and on-screen instructions reduce onboarding burden for critical care and dialysis teams, who can train in as little as 4.5 hours²
Go bagless: On-demand dialysate generation frees up RNs to focus on patient care, and builds resiliency against supply shortages
Built to move: Portable and compact footprint, well- suited for bedside treatments
Efficient infection control: eliminate need for machine isolation and bleaching when treating HBV-positive or unknown-status patients

Post-Acute & In-Center Dialysis

Powerful. Impactful. Simple.

Quanta takes the complexity out of dialysis treatment, while mitigating any staffing and infrastructure challenges.

High dose HD: 500 mL/min Qd ensures meeting dialysis adequacy
Compact and modular design: Space conserving and lightweight (71 lbs for Quanta Dialysis System), allowing for swap-and-replace model⁵
Easy to maintain: No harsh chemical disinfections or daily rinses required, only a once-weekly hot rinse⁴
NO water room needed: Ideal for rehab settings wishing to bring dialysis on-site to avoid transporting patients
Ideal for transitional care: Same platform technology can support patients for transition to self-care at home³

Home Hemodialysis

The Future of Home Dialysis is Here

Now, patients can experience Quanta’s self-care technology from the comfort of their own home.

Flexbile prescriptions: 500 mL/min Qd ensures meeting dialysis adequacy at 3x/wk, while 300 mL/min option allows for gentler & more frequent dialysis schedules
Batchless and bagless convenience: No need to prepare dialysate bateches in advance. No bags to store, carry, and dispose - Easy to maintain: No harsh chemical disinfections, one a once-weekly hot rinse
Easy to train and operate: Designed for patients and caregivers, step-by-step instructions on touchscreens guides users, with >95% success rate demonstrated in rigorous human factors testing²
Promotes patient satisfaction & retention:^2,5 84% of patients elected to continue using the Quanta Dialysis System after completing the trial⁶

“The Quanta Dialysis System represents a significant advancement in patient care, offering precision and flexibility that enhances treatment outcomes.”

Dr. Neeraja Tandra, Nephrologist, Reston, VA

Discover Kidney Care Redefined for Patients and Care Professionals with the Quanta Dialysis System

Access Quanta news, case studies, articles, and resources.

Case Study

Quanta Enhances Legacy Dialysis Operations, Expanding Treatment Flexibility and Efficiency

At Legacy Dialysis’s clinic facility in Reston, Virginia, the Quanta Dialysis System has transformed the delivery of outpatient dialysis services. By utilizing the compact combination of Quanta Dialysis System, mobile cart, and…

Blog

SLED vs. CRRT: Optimizing Acute Kidney Injury Treatment in the ICU

Despite advances in treatment, acute kidney injury (AKI) remains a significant challenge in critical care settings. Sustained Low-Efficiency Dialysis (SLED) and Continuous Renal Replacement Therapy (CRRT) are two primary modalities used in the ICU, but…

News

Quanta Dialysis Technologies® and Innovative Renal Care Announce Strategic, Multi-year Partnership

Quanta Dialysis Technologies, a leader in transforming kidney care through its award-winning Quanta Dialysis System, and Innovative Renal Care (IRC), a dialysis care provider for patients nationwide, today announced…

REFERENCES

FDA 510(k) K222067 for CVVHD and SCUF: two modalities of CRRT.
Harasemiw O., et al. Human factors testing of the Quanta SC+ hemodialysis system: An innovative system for home and clinic use. Hemodialysis Int. 2019; 23:306-313.
FDA 510(k) K242269 for HHD in tandem with a trained care partner
Quanta Dialysis System User Manual
Komenda, P., Harper, Gerard, Wilson, Lucy M., Mitra, Sandip, Breen, Cormac, and Milad (2020), Hemodialysis with the Quanta SC+: Efficacy and Safety of a Self-care Hemodialysis Machine. Kidney Medicine, Volume 2, Issue 6, 724-731. e1. https://doi.org/10.1016/j.xkme.2020.07.007
Data on File: NCT04975880

INDICATIONS FOR USE (FDA 510(k) K222067):

The Quanta Hemodialysis System (Quanta Dialysis System) is indicated for use in patients with acute and/or chronic renal failure, with or without ultrafiltration, in an acute or chronic care facility. Treatments must be administered under physician’s prescription, by a trained clinician who is competent in the use of the device. The Quanta Dialysis System is also indicated for use in the home by trained patients in tandem with a trained care partner.

The Quanta Dialysis System Blood Tube Set is a single use, disposable arterial and venous bloodline set intended to provide extracorporeal access during hemodialysis. The Blood Tubeset is compatible only with the Quanta Dialysis System System.

Treatment types available include: Intermittent Hemodialysis (IHD), Sustained Low Efficiency Dialysis (SLED/ SLEDD), Prolonged Intermittent Renal Replacement Therapy (PIRRT), Isolated Ultrafiltration including Slow Continuous Ultrafiltration (SCUF) and Continuous Venovenous Hemodialysis (CVVHD).

The Quanta Dialysis System Blood Tube Set is a single use, disposable arterial and venous bloodline set intended to provide extracorporeal access during hemodialysis. The Blood Tube Set is compatible only with the Quanta Dialysis System.

*SC+ is now known as the Quanta Dialysis System.

INDICATIONS FOR USE (FDA 510(k) K242269):

SM-313 v 1.0